Could a blast of argon plasma wipe out cervical precancer without surgery?

NCT ID NCT07730645

First seen Jul 28, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This trial tests whether a single, outpatient treatment using low-thermal argon plasma can clear grade 2 cervical intraepithelial neoplasia (CIN2), a precancerous condition. Participants receive either the plasma treatment, a sham procedure, or standard active surveillance. The main goal is to see if the plasma treatment leads to complete healing of the abnormal tissue after six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
low-thermal argon plasma devitalization (LtAPD) applied via a device
What this could lead to
If effective, this one-time outpatient procedure could offer a non-surgical way to clear high-grade cervical precancer, potentially reducing the need for more invasive treatments.
What could go wrong
This is a mid-sized trial comparing the plasma treatment to a sham procedure and active surveillance. The effect may be modest, and long-term outcomes beyond 6 months are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Tuebingen, Department of Women's Health

    Tübingen, Baden-Wurttemberg, 72076, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.